These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Sulfonylurea-responsive diabetes in childhood. Landau Z; Wainstein J; Hanukoglu A; Tuval M; Lavie J; Glaser B J Pediatr; 2007 May; 150(5):553-5. PubMed ID: 17452235 [TBL] [Abstract][Full Text] [Related]
43. [Effect of gliclazide on platelet behavior]. Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584 [No Abstract] [Full Text] [Related]
44. [On the indication and practical use of oral antidiabetics]. Fankhauser S Schweiz Med Wochenschr; 1972 Jun; 102(24):856-62. PubMed ID: 5033624 [No Abstract] [Full Text] [Related]
45. [Progress in oral antidiabetic therapy]. Rambert P Therapeutique; 1973 Nov; 49(9):555-6. PubMed ID: 4600034 [No Abstract] [Full Text] [Related]
47. Actual problems of the hypoglycaemic sulfonylureas. Káldor A Ther Hung; 1977; 25(2):47-50. PubMed ID: 898117 [No Abstract] [Full Text] [Related]
48. [Treatment of diabetes with low doses of glypizide]. Lozano-Castañeda O; Schulte J; Gonzálex Barranco J; García Viveros M; Rull JA Prensa Med Mex; 1974; 39(7-8):358-61. PubMed ID: 4453534 [No Abstract] [Full Text] [Related]
49. Oral hypoglycaemic drugs--in treatment of diabetes mellitus. Cheung E Aust Nurses J; 1977 Aug; 7(2):29-31. PubMed ID: 244289 [No Abstract] [Full Text] [Related]
50. [Mechanism of the antidiabetic action of sulfanylurea derivatives]. Iaroshevskiĭ IuA; Volkova EA Klin Med (Mosk); 1982 Oct; 60(10):94-7. PubMed ID: 6757562 [No Abstract] [Full Text] [Related]
51. Sulfonylureas: background and development of the field. Levine R Diabetes Care; 1984; 7 Suppl 1():3-7. PubMed ID: 6376027 [TBL] [Abstract][Full Text] [Related]
52. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). 1. Establishment of proof and methods]. Lehnert J; Kiesselbach NH; Blumenbach L Arzneimittelforschung; 1974 Mar; 24(0):433-7. PubMed ID: 4603693 [No Abstract] [Full Text] [Related]
54. [Glydiazinamide-induced changes in the oral glucose tolerance of 15 adult diabetics]. Vailati G; Montini M; Pagani G; Caputo G Minerva Med; 1972 Oct; 63(69):3752-7. PubMed ID: 5078667 [No Abstract] [Full Text] [Related]
55. [Oral antidiabetics of the sulfonylurea group and their problems in therapy]. Füsgen I; Summa JD Z Gerontol; 1980; 13(1):45-51. PubMed ID: 7456613 [TBL] [Abstract][Full Text] [Related]
56. Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2. Jackson JE; Bressler R Drugs; 1981 Oct; 22(4):295-320. PubMed ID: 7030708 [No Abstract] [Full Text] [Related]
57. [Diabetes mellitus. Experience with prolonged administration of oral antidiabetics]. Thönelt K ZFA (Stuttgart); 1976 Jun; 52(17):921-2. PubMed ID: 945647 [No Abstract] [Full Text] [Related]
58. Pharmacologic management of diabetes mellitus. Mozersky RP J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525 [TBL] [Abstract][Full Text] [Related]
59. [Basic trends in the therapy of diabetes mellitus]. Perelygina AA Vestn Akad Med Nauk SSSR; 1983; (2):56-9. PubMed ID: 6837139 [No Abstract] [Full Text] [Related]
60. [Platelet adhesiveness and diamicron in human clinical practice]. Daver J; Izarn P; Menache D; Paleirac G; Streiff F Therapeutique; 1973 Apr; 49(4):279-82. PubMed ID: 4775222 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]